PinpointBio is a technology company that provides an AI-driven platform for structured evidence synthesis in drug development. The platform is designed to assist pharmaceutical and biotechnology organizations in making data-driven decisions by evaluating targets and disease pathology across core evidence domains.
The company focuses on creating agentic intelligence tools that aim to make drug development evaluation more reproducible, auditable, and decision-ready. Their services include competitive landscape analysis, target biology assessment, and mechanism of action evaluation.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:AI-driven Drug Discovery/Informatics
SIZE & FINANCIALS
Ownership:private
Status:operating
0
COMPETITION
Position:Emerging
LINKS
Website:pinpointbio.ai
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PinpointBio and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PinpointBio. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.